Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Cash & Current Investments: 2018

Historic Cash & Current Investments for DiaMedica Therapeutics (DMAC) over the last 1 years, with Dec 2018 value amounting to $16.8 million.

  • DiaMedica Therapeutics' Cash & Current Investments rose 149.95% to $9.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $51.2 million, marking a year-over-year change of. This contributed to the annual value of $16.8 million for FY2018, which is N/A change from last year.
  • According to the latest figures from FY2018, DiaMedica Therapeutics' Cash & Current Investments is $16.8 million.
  • In the past 5 years, DiaMedica Therapeutics' Cash & Current Investments ranged from a high of $16.8 million in FY2018 and a low of $16.8 million during FY2018.
  • Its 1-year average for Cash & Current Investments is $16.8 million, with a median of $16.8 million in 2018.